GLP1R and type 2 diabetes mellitus: These studies recapitulated animal studies, where infusion of GLP-1 analogs was found to; attenuate neuronal activity in reward processing areas, reduce appetite and hedonic feeding in healthy volunteers (264), as well as obese and T2DM patients (265, 266).